NIH-funded research R21 grant

How bacterial proteins affect human cell function

Official title: Mechanisms of histone crosstalk with bacterial pathogens

Funded at Van Andel Research Institute · NIH-10744241 · Data updated 2026-11-12

This study is looking at how proteins from the bacteria Legionella pneumophila can change how our cells work, which might help us understand better ways to treat infections caused by these germs.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionVan Andel Research Institute
NIH-funded
Lab location1 site (Grand Rapids, United States)
Project startNovember 18, 2022
Project endOctober 31, 2025
Funding year2024
Award (this year)$237,500
NIH project number5R21AI173758-02
Project IDNIH-10744241 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have been diagnosed with infections caused by Legionella pneumophila or similar bacterial pathogens.

Less likely to help

Patients with infections caused by non-bacterial pathogens or those without any infectious diseases may not benefit from this research.

What this research studies

This research investigates how certain proteins secreted by bacterial pathogens, specifically Legionella pneumophila, interact with human cells to alter their function. The focus is on understanding how these proteins, known as nucleomodulins, modify the epigenetic landscape of host cells, particularly by affecting histone modifications. By studying the mechanisms of these interactions, the research aims to uncover how bacterial infections can manipulate host immune responses and cellular processes. This could lead to new insights into the treatment of infections caused by these pathogens.

Why it matters

Potential benefit: If successful, this research could lead to novel therapeutic strategies for treating infections by targeting the mechanisms used by bacteria to evade the immune system.

How similar studies have gone: Other research has shown success in understanding host-pathogen interactions through similar mechanisms, indicating that this approach has potential for significant findings.

Where this research is happening

  • Van Andel Research Institute
    Grand Rapids, United States
    Active

Researchers

  • Principal investigator: Worden, Evan J — Van Andel Research Institute
  • Study coordinator: Worden, Evan J

Related research

Other NIH-funded projects on the same topics.

  • Histone mutations in cancer pathogenesis

    A cancer-focused study looks at how changes in histone genes found in patients may drive tumor growth and interact with other cancer mutations.

    NIH research Van Andel Research Institute · Grand Rapids, United States · NIH-11519685

  • circSATB2: a new regulator in arsenic-related cancer

    A new gene-related mechanism linked to arsenic exposure and cancer is being studied to understand how a circular RNA from SATB2 may influence cancer development.

    NIH research Van Andel Research Institute · Grand Rapids, United States · NIH-11467706

  • Bacteria that influence insulin signaling and Type 2 diabetes

    Researchers will study gut bacteria that may change how insulin works in the body, with a focus on diabetes risk.

    NIH research Van Andel Research Institute · Grand Rapids, United States · NIH-11455824

  • Understanding how amyloid plaques form in Alzheimer's disease

    A research project will look at how misfolded amyloid proteins build up in the brains of people and mouse models with Alzheimer’s disease to uncover new clues for diagnosis and treatment.

    NIH research Van Andel Research Institute · Grand Rapids, United States · NIH-11448261

  • How DNA methylation patterns are kept in colon cancer and what happens when they’re disrupted

    Researchers are studying how the molecular marks that control gene activity are maintained in colon cancer and how breaking these marks affects cancer growth and treatment response.

    NIH research Van Andel Research Institute · Grand Rapids, United States · NIH-11447596

  • ER quality control across cell types with unique ER shapes

    A scientist will study how the endoplasmic reticulum keeps cells healthy by managing its structure and stress responses in different cell types, including neurons.

    NIH research Van Andel Research Institute · Grand Rapids, United States · NIH-11428039

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.